2. Cell Cycle/DNA Damage
  3. DNA/RNA Synthesis
  4. BMH-21

BMH-21 is a first-in-class DNA intercalator which inhibits RNA polymerase I (Pol I) transcription. BMH-21 possesses anticancer activity.

商品は「研究用試薬」です。人や動物の医療用・臨床診断用・食品用の製品ではありません。
研究用途以外に使用した場合、当社は一切の責任を負いかねます。

CAS 番号 : 896705-16-1

容量 価格（税別） 在庫状況 数量
>無料サンプル (0.1 - 0.2 mg)   今すぐ申し込む  
5 mg $46 在庫あり
10 mg $72 在庫あり
25 mg $135 在庫あり
50 mg $220 在庫あり
100 mg $385 在庫あり
500 mg $1320 在庫あり
1 g   お問い合わせ  
5 g   お問い合わせ  

* アイテムを追加する前、数量をご選択ください

This product is a controlled substance and not for sale in your territory.

カスタマーレビュー

Based on 14 publication(s) in Google Scholar

BMH-21 関連抗体

Top Publications Citing Use of Products

    BMH-21 purchased from MedChemExpress. Usage Cited in: Mol Cell. 2025 Mar 6;85(5):894-912.e10.  [Abstract]

    BMH-21 (10 μM; 6 h) decreased MCL1, CCND3, and MYB similarly regardless of SLFN11 in CCRF-CEM cells.

    BMH-21 purchased from MedChemExpress. Usage Cited in: Mol Cell. 2025 Mar 6;85(5):894-912.e10.  [Abstract]

    BMH-21 (10 μM) activated apoptosis independently of SLFN11 in CCRF-CEM cells, with similar kinetics to SLFN11-dependent apoptosis.

    BMH-21 purchased from MedChemExpress. Usage Cited in: Mol Cell. 2025 Mar 6;85(5):894-912.e10.  [Abstract]

    The RNA polymerase I (POLR1) inhibitors BMH-21 (10 µM; 6 h) drastically reduced EU incorporation in leukemia MOLT4 irrespective of SLFN11 expression.

    BMH-21 purchased from MedChemExpress. Usage Cited in: Mol Cancer. 2024 Dec 20;23(1):275.  [Abstract]

    BMH-21 (5 µM) caused a significant delay in growth of mouse fibrosarcoma MCA205 cells and kept a significant percentage of mice alive and tumor-free.

    BMH-21 purchased from MedChemExpress. Usage Cited in: Mol Cancer. 2024 Dec 20;23(1):275.  [Abstract]

    Systemic treatment of mice bearing established tumors with BMH-21 (50 mg/kg; i.p.) significantly reduced tumor progression, and this effect was lost upon in vivo depletion of T cells by monoclonal antibodies specific for CD4 and CD8.

    DNA/RNA Synthesis アイソフォーム固有の製品をすべて表示:

    すべてのアイソフォームを表示
    RNASE L DNA Polymerases RNA Polymerases Helicases DNA Ligase

    • 生物活性

    • 純度とドキュメンテーション

    • 参考文献

    • カスタマーレビュー

    製品説明

    BMH-21 is a first-in-class DNA intercalator which inhibits RNA polymerase I (Pol I) transcription. BMH-21 possesses anticancer activity[1][2].

    IC50 & Target

    RNA Polymerase

     

    Cellular Effect
    Cell Line Type Value Description References
    HeLa IC50
    0.46 3
    Compound: BMH-21
    Cytotoxicity against human HeLa cells
    Cytotoxicity against human HeLa cells
    		[PMID: 34124673]
    U2OS IC50
    0.05 3
    Compound: 2, BMH-21
    Induction of RNA polymerase-1 RPA194 subunit degradation in human U2OS cells after 3 hrs by epifluorescence microscopic analysis
    Induction of RNA polymerase-1 RPA194 subunit degradation in human U2OS cells after 3 hrs by epifluorescence microscopic analysis
    		[PMID: 24847734]
    HeLa IC50
    0.46 3
    Compound: BMH-21
    Cytotoxicity against human HeLa cells
    Cytotoxicity against human HeLa cells
    		[PMID: 34124673]
    U2OS IC50
    0.07 3
    Compound: 2, BMH-21
    Inhibition of RNA polymerase-1 in human U2OS cells assessed as decrease in nucleolar localization of nucleolin after 3 hrs by epifluorescence microscopic analysis
    Inhibition of RNA polymerase-1 in human U2OS cells assessed as decrease in nucleolar localization of nucleolin after 3 hrs by epifluorescence microscopic analysis
    		[PMID: 24847734]
    U2OS IC50
    0.05 3
    Compound: 2, BMH-21
    Induction of RNA polymerase-1 RPA194 subunit degradation in human U2OS cells after 3 hrs by epifluorescence microscopic analysis
    Induction of RNA polymerase-1 RPA194 subunit degradation in human U2OS cells after 3 hrs by epifluorescence microscopic analysis
    		[PMID: 24847734]
    U2OS IC50
    0.05 3
    Compound: 2, BMH-21
    Induction of RNA polymerase-1 RPA194 subunit degradation in human U2OS cells after 3 hrs by epifluorescence microscopic analysis
    Induction of RNA polymerase-1 RPA194 subunit degradation in human U2OS cells after 3 hrs by epifluorescence microscopic analysis
    		[PMID: 24847734]
    U2OS IC50
    0.07 3
    Compound: 2, BMH-21
    Inhibition of RNA polymerase-1 in human U2OS cells assessed as decrease in nucleolar localization of nucleolin after 3 hrs by epifluorescence microscopic analysis
    Inhibition of RNA polymerase-1 in human U2OS cells assessed as decrease in nucleolar localization of nucleolin after 3 hrs by epifluorescence microscopic analysis
    		[PMID: 24847734]
    U2OS IC50
    0.07 3
    Compound: 2, BMH-21
    Inhibition of RNA polymerase-1 in human U2OS cells assessed as decrease in nucleolar localization of nucleolin after 3 hrs by epifluorescence microscopic analysis
    Inhibition of RNA polymerase-1 in human U2OS cells assessed as decrease in nucleolar localization of nucleolin after 3 hrs by epifluorescence microscopic analysis
    		[PMID: 24847734]
    体外実験

    BMH-21 binds ribosomal DNA and inhibits Pol I transcription[1].
    BMH-21 inhibits RNA polymerase I independent of DNA damage response[1].
    BMH-21 intercalates into double strand (ds) DNA and has binding preference towards GC-rich DNA sequences[1].
    BMH-21 (1 μM; 3 hours) acts in a DNA damage independent manner to activate nucleolar stress and RPA194 degradation[1].

    MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

    BMH-21 関連抗体

    Cell Viability Assay[1]

    Cell Line: U2OS cells
    Concentration: 0 μM, 0.1 μM , 1 μM, 10 μM
    Incubation Time: 48 hours
    Result: Decreased the viability of cells at concentrations that activated the DNA damage response.

    Western Blot Analysis[1]

    Cell Line: A375 cells
    Concentration: 1 μM
    Incubation Time: 3 hours
    Result: Degraded RPA194 with blocked ATM and DNA-PKcs activity.
    体内実験

    BMH-21 (50 mg/kg; i.p.; daily; for 6 days) inhibits HCT116 colon cancer tumor growth in vivo[2].

    MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

    Animal Model: 6-week old athymic NCr nu/nu mice, with HCT116 colorectal carcinoma xenograft[2]
    Dosage: 50 mg/kg
    Administration: Intraperitoneal injection, daily, for 6 days
    Result: Significantly inhibited HCT116 colon cancer tumor growth.
    分子量

    360.41

    分子式

    C21H20N4O2
    CAS 番号
    Appearance

    Solid

    Color

    Yellow to orange

    SMILES

    O=C(C1=CC=CN2C1=NC3=C(C=C4C(C=CC=C4)=C3)C2=O)NCCN(C)C
    輸送条件

    Room temperature in continental US; may vary elsewhere.
    保管条件
    Powder -20°C 3 years
      4°C 2 years
    In solvent -80°C 6 months
      -20°C 1 month
    溶剤 & 溶解度
    体外: 

    DMSO : 1 mg/mL (2.77 mM; Need ultrasonic; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)

    Preparing
    Stock Solutions
    Concentration Solvent Mass 1 mg 5 mg 10 mg
    1 mM 2.7746 mL 13.8731 mL 27.7462 mL
    5 mM --- --- ---
    10 mM --- --- ---
    View the Complete Stock Solution Preparation Table

    * Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
    Storage method and period of stock solution: -80°C, 2 years; -20°C, 1 year. When stored at -80°C, please use it within 2 years. When stored at -20°C, please use it within 1 year.

    • Molarity Calculator

    • Dilution Calculator

    Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

    Mass
    =
    Concentration
    ×
    Volume
    ×
    Molecular Weight *

    Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

    一般には略語で表示されます：C1V1 = C2V2

    濃度 （開始）

    C1

    ×
    体積 （開始）

    V1

    =
    濃度 （終了）

    C2

    ×
    体積 （終了）

    V2

    体内:

    For the following dissolution methods, please prepare the working solution directly. It is recommended to prepare fresh solutions and use them promptly within a short period of time.
    The percentages shown for the solvents indicate their volumetric ratio in the final prepared solution. If precipitation or phase separation occurs during preparation, heat and/or sonication can be used to aid dissolution.

    • Protocol 1

      Add each solvent one by one:  50% PEG300    50% Saline

      Solubility: 25 mg/mL (69.37 mM); Suspended solution; Need ultrasonic

    In Vivo Dissolution Calculator
    Please enter the basic information of animal experiments:

    Dosage

    mg/kg

    Animal weight
    (per animal)

    g

    Dosing volume
    (per animal)

    μL

    Number of animals

    Recommended: Prepare an additional quantity of animals to account for potential losses during experiments.
    Calculation results:
    Working solution concentration: mg/mL
    純度とドキュメンテーション
    参考文献

    Complete Stock Solution Preparation Table

    * Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
    Storage method and period of stock solution: -80°C, 2 years; -20°C, 1 year. When stored at -80°C, please use it within 2 years. When stored at -20°C, please use it within 1 year.

    Optional Solvent Concentration Solvent Mass 1 mg 5 mg 10 mg 25 mg
    DMSO 1 mM 2.7746 mL 13.8731 mL 27.7462 mL 69.3654 mL
    • No file chosen (Maximum size is: 1024 Kb)
    • If you have published this work, please enter the PubMed ID.
    • Your name will appear on the site.

    BMH-21 Related Classifications

    • Molarity Calculator

    • Dilution Calculator

    The molarity calculator equation

    Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

    質量   濃度   体積   分子量 *
    = × ×

    The dilution calculator equation

    Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

    一般には略語で表示されます：C1V1 = C2V2

    濃度 （開始） × 体積 （開始） = 濃度 （終了） × 体積 （終了）
    × = ×
    C1   V1   C2   V2
    Help & FAQs
    • Do most proteins show cross-species activity?

      Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

    Keywords:

    BMH-21896705-16-1BMH21BMH 21DNA/RNA SynthesisDNAintercalationdamageresponsetranscriptionRNApolymeraseInucleolusInhibitorinhibitorinhibit

    最近チェックした製品:

    オンラインお問い合わせ

    Your information is safe with us. * Required Fields.

    製品名

    		  

    カスタマ需要量 *

    お名前 *

    		 

    タイトル

    メールアドレス *

    		 

    電話番号 *

    デパートメント

    		 

    組纖名 *

    市区町村

    都道府県

    国或いは地域 *

    		      

    必ず会社名を記載ください。個人への返信は行いません。

    備考

    バルクお問い合わせ

    Inquiry Information

    製品名:
    BMH-21
    製品番号:
    HY-12484
    数量:
    MCE 日本正規代理店:

    カスタマーレビュー

    Thank You for Your Feedback!

    Request for HNMR Report

    Please fill out this form to request the QC report. We will send it to your Email address shortly.

    Your information is safe with us. * Required Fields.

    製品名

    		  

    Lot #

    お名前 *

    		 

    メールアドレス *

    電話番号 *

    		 

    部門 *

    組纖名 *

    		 

    国或いは地域 *

    備考

    Request for HNMR Report

    We have received your request and will respond to you as soon as possible.